New biomarker insights drive higher clinical trial efficacy
Your challenges and opportunities
Share on:
Discussion Paper – Biomarker roles within clinical trials
In this discussion paper, Gavin Coney sets out the key trends in targeted clinical strategies and examines how biomarkers are being applied within trial design and in the selection of patients. He goes on to explore how to demonstrate efficacy and suggests areas to focus on to drive success.
Cortellis
from Clarivate Analytics
With comprehensive information on clinical trials and rare diseases, gene variant and biomarker indexing, and links to biomarker and ontology APIs, Cortellis delivers what you need to improve trials success rates.
Cortellis Clinical Trials Intelligence holds expertly curated information on over 250,000 trials with extensive data on patient segmentation. Get detailed insights on specific trial designs including biomarkers, targets and indications.
Identify trial designs associated with success or failure around: end points, inclusion/exclusion criteria, active control, dose range/regime. Save time analyzing findings and develop new insights with clear and dynamic visualizations.
Further, with the Biomarkers Module of Integrity, you get in-depth information to support the identification and validation of biomarkers to use in patient stratification.
Contact Sales
Learn how we can help you get insights to accelerate your clinical development decisions
Cortellis Clinical Trials Intelligence
Global intelligence, providing you with the insights to make better decisions on your clinical strategy
Current Customers
Quick Links
Global Sites
Follow
@IPLifecycle
Clarivate Analytics